Pichia Expression Platform

Join us at the Pichia 2024 Conference in San Diego!

RCT’s Pichia Expression Platform includes the Pichia Classic System as well as Pichia GlycoSwitch® System which enables human-like glycosylation in yeast. Pichia pastoris is well established for the rapid and cost-effective expression of recombinant proteins from discovery through commercialization.  Pichia has been used to successfully produce proteins across a broad spectrum of functional types including enzymes, antigens, engineered antibody fragments, and next gen protein scaffolds. Benefits of Pichia expression include:

• Soluble proteins
• High cell densities/high protein yield
• Controllable process
• Minimal downstream purification or processing
• Products similar to those produced in mammalian systems

Learn More

Pichia Expression Kits, Custom Services, and Technical Support

RCT has several partners to ensure the development and availability of Pichia expression systems. These partners include leading life science companies that provide kits, custom services and technical support. Kits that contain Pichia Classic strains and vectors are available from our partner Life Technologies. Pichia GlycoSwitch® kits and services are available from our partner Biogrammatics. Pichia custom protein production services are also available from a number of service providers.

Learn More

Pichia Licensing Program

RCT acquired the original patents and related materials covering Pichia Expression strains and vectors from Philips Petroleum in 1993. Invitrogen, now Life Technologies retains a license to sell Pichia Expression kits and related materials. Over the years there have been numerous additions to the collection of available strains, vectors and supporting materials offered by Life Technologies.

The Pichia Classic Expression System includes all the strains and vectors offered by Life Technologies. The Pichia GlycoSwitch® System includes only the Pichia GlycoSwitch® strains and vectors which are dedicated to the expression and production of glycoproteins.

Research Corporation Technologies (RCT) has established a licensing program for easy access to either Pichia Classic or Pichia GlycoSwitch® expression systems. For both systems, Kits can be purchased and the systems evaluated for a period of one-year under a limited-use license.

Learn More

Frequently Asked Questions

The Pichia Expression Platform is the most economical eukaryotic expression system for both secretion and intracellular expression. It is ideally suitable for large-scale production of recombinant proteins. Utilizing Pichia expression can avoid problems such as insoluble proteins and inclusion bodies, thus saving you time and money. Find out more about the advantages of Pichia expression and answers to some of the General frequetly asked questions and Fermentation specific questions.